Delos Capital Partners Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
13
- Investments
-
38
- Portfolio
-
23
- Exits
-
8
Delos Capital Partners General Information
Description
Founded in 2014, Delos Capital Partners is a venture capital firm based in Hong Kong. The firm prefers to invest in seed-stage, early-stage, and later-stage companies. The firm also specializes in private equity investments. The firm seeks to invest in healthcare, life sciences, and technology-based sectors in the United States and East Asia.
Contact Information
Website
www.deloscapital.com
Year Founded
2014
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
PE/Buyout
Primary Office
- 19/F Fung House
- 19 - 20 Connaught Road Central
- Hong Kong
- Hong Kong
+852 3912 0000
Delos Capital Partners Investments (38)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Ensoma | 16-May-2023 | Early Stage VC | 00000 | Drug Discovery | Clinical Trials - General | |
| 000000 | 07-Dec-2022 | 00000 00000 | 0000 | Surgical Devices | Pre-Clinical Trials | |
| 000000 00000000000 | 29-Nov-2022 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | |
| 000000 00000 | 16-Sep-2022 | 00000 00000 | 00.000 | Other Healthcare Technology Systems | Generating Revenue | |
| 00000 000000000000 | 22-Feb-2022 | 000000000000 | Drug Discovery | Startup | 000 0000 | |
| 0000000 0000000000 | 08-Dec-2021 | 00000 00000 | 0000 | Drug Discovery | Out of Business | 000 0000 |
| 000000 00000000000 | 03-Nov-2021 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | 00000 0000 00 |
| 0000000000 0000 | 15-Jul-2021 | 00000 00000 | 00000 | Surgical Devices | Generating Revenue | 00000 0000 00 |
| LifeQ | 26-May-2021 | Later Stage VC | 0000 | Therapeutic Devices | Generating Revenue | |
| Phanes Therapeutics | 06-May-2021 | Later Stage VC | 0000 | Drug Discovery | Clinical Trials - Phase 1 |
Delos Capital Partners Exits (8)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| OncoMyx Therapeutics | 01-Jul-2022 | Out of Business | |
| 000000 00000000000 | 05-Nov-2021 | 000 | 00000 |
| 000000 | 15-Jul-2021 | 000000000000000000 | |
| 0000 0000000000000 | 01-Feb-2021 | 000000000000000000 | 00000 |
| 000000 | 15-Mar-2018 | 000000000 00000000 | |
| 00000 0000000 | 10-Oct-2017 | 000000000000000000 | 00000 |
| Syndax | 03-Mar-2016 | IPO | 000.00 |
| Tanvex Biopharma | 13-Aug-2015 | IPO |
Delos Capital Partners Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Delos Capital Partners Team (22)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Henry Chen JD | Founder & Managing Partner | 00 | 0 | 00 | Hong Kong, Hong Kong |
| Tim Xiao | Partner & Founding Team Member | 0 | 0 | 0 | Hong Kong, Hong Kong |
| Chi-Chuan Chen | Partner | 0 | Hong Kong, Hong Kong | ||
| Michael Chang Ph.D | Partner | 0 | Hong Kong, Hong Kong | ||
| Samuel Yin Ph.D | Partner | Hong Kong, Hong Kong |
Delos Capital Partners Co-Investors (120)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| AMED Ventures | 4 | 0 | 0 |
|
|
| Ascension Ventures | 0 | 0 | 0 |
|
|
| Boehringer Ingelheim Venture Fund | 0 | 0 | 0 |
|
|
| Lumira Ventures | 0 | 0 | 0 |
|
|
| Hillhouse Capital Group | 0 | 0 | 0 |
|
|